More
Posted inCoronavirus Updates

Merck v Pfizer: Here’s how the two new COVID antiviral drugs work and will be used

London (The Conversation): We’ve waited 20 months for a medicine to blunt the coronavirus, and now two have appeared. Earlier this month, the UK medicines regulator approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. Among adults with mild to moderate COVID who were at risk of developing a serious disease, it cut […]